Bayer, Johnson and Johnson's heart drug Xarelto fails trial to widen use Ruby Khatun Khatun28 Aug 2018 4:15 AM GMTFRANKFURT: Bayer and Johnson and Johnson's campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential...
Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity Ruby Khatun Khatun28 Aug 2017 7:35 AM GMTFRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...